Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interactionWALSH, Thomas J; SHOHAM, Shmuel; PETRAITIENE, Ruta et al.Journal of clinical microbiology (Print). 2004, Vol 42, Num 10, pp 4744-4748, issn 0095-1137, 5 p.Article

Pharmacological Basis of β-Lactamase Inhibitor Therapeutics: Tazobactam in Combination with CeftolozaneVANSCOY, Brian; MENDES, Rodrigo E; AMBROSE, Paul G et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 12, pp 5924-5930, issn 0066-4804, 7 p.Article

Impact of Renal Function on the Pharmacokinetics and Safety of Ceftolozane-TazobactamWOOLEY, Myra; MILLER, Benjamin; KRISHNA, Gopal et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 4, pp 2249-2255, issn 0066-4804, 7 p.Article

Intervention study of the association of antibiotic utilization measures with control of extended-spectrum β-lactamase (ESBL)-producing bacteriaZHONGGUANG WEN; XIAOYANG WEI; YONGHONG XIAO et al.Microbes and infection. 2010, Vol 12, Num 10, pp 710-715, issn 1286-4579, 6 p.Article

Concentrations of piperacillin-tazobactam in human jaw and hip boneAL-NAWAS, Bilal; KINZIG-SCHIPPERS, Marion; SOERGEL, Fritz et al.Journal of cranio-maxillo-facial surgery. 2008, Vol 36, Num 8, pp 468-472, issn 1010-5182, 5 p.Article

Detection of bacterial strains producing sulbactam or tazobactam-sensitive β-lactamases by the use of disks containing the inhibitors alone instead of combining them with antibioticsBANIC, S.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2006, Vol 114, Num 1, pp 3-9, issn 0903-4641, 7 p.Article

In vitro activity of piperacillin/tazobactam and ertapenem against Bacteroides fragilis and Escherichia coli in pure and mixed culturesDOS SANTOS, Kênia Valéria; DINIZ, Claudio Galuppo; COUTINHO, Simone Cristina et al.Journal of medical microbiology. 2007, Vol 56, Num 6, pp 798-802, issn 0022-2615, 5 p.Article

Effect of subinhibitory concentration of piperacillin/tazobactam on Pseudomonas aeruginosaFONSECA, A. P; EXTREMINA, C; FONSECA, A. F et al.Journal of medical microbiology. 2004, Vol 53, Num 9, pp 903-910, issn 0022-2615, 8 p.Article

False positive galactomannan Platelia due to piperacillin-tazobactamGERLINGER, M. P; ROUSSELOT, P; RIGAUDEAU, S et al.Médecine et maladies infectieuses. 2012, Vol 42, Num 1, pp 10-14, issn 0399-077X, 5 p.Article

β-LACTAMASE INHIBITORS DISPLAY ANTI-SEIZURE PROPERTIES IN AN INVERTEBRATE ASSAYRAWLS, S. M; KARACA, F; MADHANI, I et al.Neuroscience. 2010, Vol 169, Num 4, pp 1800-1804, issn 0306-4522, 5 p.Article

In vitro potency evaluations of various piperacillin/tazobactam generic products compared with the contemporary branded (Zosyn®, Wyeth) formulationJONES, Ronald N; FRITSCHE, Thomas R; MOET, Gary J et al.Diagnostic microbiology and infectious disease. 2008, Vol 61, Num 1, pp 76-79, issn 0732-8893, 4 p.Article

Effectiveness of drug use evaluation and antibiotic authorization on patients' clinical outcomes, antibiotic consumption, and antibiotic expendituresRATTANAUMPAWAN, Pinyo; SUTHA, Patama; THAMLIKITKUL, Visanu et al.American journal of infection control. 2010, Vol 38, Num 1, pp 38-43, issn 0196-6553, 6 p.Article

In-vitro activity of piperacillin and tazobactam combination against clinically significant bacteriaOBI, C. L; MAKANDIRAMBA, B; ROBERTSON, V et al.East African medical journal. 1998, Vol 75, Num 3, pp 162-165, issn 0012-835XArticle

Reproducibility assessment of tigecycline MIC results by broth microdilution methods using commercially prepared dry-form panelsRHOMBERG, Paul R; JONES, Ronald N.Diagnostic microbiology and infectious disease. 2005, Vol 52, Num 1, pp 67-69, issn 0732-8893, 3 p.Article

Comparative activities of cefepime and piperacillin/tazobactam tested against a global collection of Escherichia coli and Klebsiella spp. with an ESBL phenotypeSADER, Helio S; HSIUNG, Andre; FRITSCHE, Thomas R et al.Diagnostic microbiology and infectious disease. 2007, Vol 57, Num 3, pp 341-344, issn 0732-8893, 4 p.Article

Risk factors for piperacillin/tazobactam-resistant Escherichia coli in ICU patients: a clinical studyMOHAMMEDI, Ismaël; PLOIN, Dominique; DUPERRET, Serge et al.Intensive care medicine (Print). 2003, Vol 29, Num 7, pp 1164-1168, issn 0342-4642, 5 p.Article

Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum β-lactamase-producing and extended-spectrum β-lactamase-non-producing Escherichia coli isolatesLOPEZ-CERERO, L; PICON, E; MORILLO, C et al.Clinical microbiology and infection. 2010, Vol 16, Num 2, pp 132-136, issn 1198-743X, 5 p.Article

Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infectionsWASAN PATEL, Gita; PATEL, Nimish; LAT, Asma et al.Diagnostic microbiology and infectious disease. 2009, Vol 64, Num 2, pp 236-240, issn 0732-8893, 5 p.Article

Serum piperacillin/tazobactam pharmacokinetics in a morbidly obese individualNEWMAN, Diane; SCHEETZ, Marc H; ADEYEMI, Oluwadamilola A et al.The Annals of pharmacotherapy. 2007, Vol 41, Num 10, pp 1734-1739, issn 1060-0280, 6 p.Article

Piperacillin/tazobactam-induced paresthesiaeLAMBOURNE, Jonathan; KITCHEN, Joanne; HUGHES, Claudine et al.The Annals of pharmacotherapy. 2006, Vol 40, Num 5, pp 977-979, issn 1060-0280, 3 p.Article

In vitro activity of piperacillin/tazobactam and other broad-spectrum antibiotics against bacteria from hospitalised patients in the British IslesLIVERMORE, D. M; MUSHTAQ, S; JAMES, D et al.International journal of antimicrobial agents. 2003, Vol 22, Num 1, pp 14-27, issn 0924-8579, 14 p.Article

Population Pharmacokinetics of Piperacillin/Tazobactam in Critically III Young ChildrenCIES, Jeffrey J; SHANKAR, Venkat; SCHLICHTING, Christine et al.The Pediatric infectious disease journal. 2014, Vol 33, Num 2, pp 168-173, issn 0891-3668, 6 p.Article

Proteomic analysis of Escherichia coli with experimentally induced resistance to piperacillin/tazobactamDOS SANTOS, Kênia Valéria; GALUPPO DINIZ, Cláudio; DE CASTRO VELOSO, Luciano et al.Research in microbiology (Paris). 2010, Vol 161, Num 4, pp 268-275, issn 0923-2508, 8 p.Article

Piperacillin-tazobactam monotherapy in high-risk febrile and neutropenic cancer patientsVISCOLI, C; COMETTA, A; KERN, W. V et al.Clinical microbiology and infection. 2006, Vol 12, Num 3, pp 212-216, issn 1198-743X, 5 p.Article

High performance liquid chromatographic determination of plasma free and total tazobactam and piperacillinDI GIOVAMBERARDINO, Gianna; FERRANNINI, Michele; PIERO TESTORE, Gian et al.Journal of chromatography. B. 2009, Vol 877, Num 1-2, pp 86-88, issn 1570-0232, 3 p.Article